Home LiteratureArticle Details
PMID: 10948107 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Phagocytic cell killing mediated by secreted cytotoxic factors of Vibrio cholerae.

Infection and immunity ·Vol. 68 ·No. 9 ·2000-09-00 ·Pages 4930-7

Punj V, Zaborina O, Dhiman N, Falzari K, Bagdasarian M, Chakrabarty AM

Abstract

Vibrio cholerae strain VB1 secretes a number of enzymes into the outside medium that utilize ATP as a substrate. Such enzymes are found in the outside medium during the mid-log phase of growth, when the optical density at 650 nm is about 0.4, and they demonstrate nucleoside diphosphate kinase (Ndk), 5' nucleotidase, and adenylate kinase (Ak) activities. We report that the filtered growth medium of V. cholerae, as well as the flowthrough fraction of a green Sepharose column during fractionation of the growth medium, had very little cytotoxicity by itself towards macrophages and mast cells but exhibited significant cytotoxicity in the presence of exogenous ATP. Such fractions, harboring 5' nucleotidase, Ndk, and presumably other ATP-utilizing enzymes, demonstrated enhanced macrophage and mast cell death; periodate-oxidized-ATP (oATP)-treated macrophage and mast cells or such cells exposed to 0.1 mM Mg(2+), where surface-associated P2Z receptors could not be activated, were not susceptible to subsequent ATP addition. Microscopic visualization of mast cells clearly demonstrated cell morphological changes such as swelling, vacuolization, and nuclear fragmentation following treatment with ATP and the growth medium of V. cholerae; however, these effects were suppressed if the mast cells were pretreated with oATP. These results strongly imply that the secreted ATP-utilizing enzymes of V. cholerae modulate the external ATP levels of the macrophage and mast cells, leading to their accelerated death, presumably through activation of P2Z receptors. Thus, development of inhibitors for such enzymes may reduce the level of V. cholerae infection; alternatively, mutations in such genes may eliminate V. cholerae survival in the gut and contribute to a safer live vaccine.

MeSH Terms
5'-Nucleotidase/metabolism Adenosine Triphosphate/metabolism Adenylate Kinase/metabolism Animals Cell Death Chromatography, High Pressure Liquid Macrophages/pathology Mast Cells/pathology Mice Mice, Inbred BALB C Phagocytes/pathology Receptors, Purinergic P2/physiology Vibrio cholerae/pathogenicity Virulence
Chemicals
Receptors, Purinergic P2 Adenosine Triphosphate Adenylate Kinase 5'-Nucleotidase
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Punj V
Department of Microbiology & Immunology, University of Illinois College of Medicine, Chicago, Illinois 60612, USA.
Zaborina O
Dhiman N
Falzari K
Bagdasarian M
Chakrabarty A M
References (29)
29 references, click to expand
  1. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages.
    J Immunol. 1997 Aug 1;159(3):1451-8 PMID: 9233643
  2. P2Z-Independent and P2Z receptor-mediated macrophage killing by Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Infect Immun. 1999 Oct;67(10):5231-42 PMID: 10496900
  3. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors.
    Immunity. 1997 Sep;7(3):433-44 PMID: 9324363
  4. The Vibrio cholerae O139 Calcutta bacteriophage CTXphi is infectious and encodes a novel repressor.
    J Bacteriol. 1999 Nov;181(21):6779-87 PMID: 10542181
  5. Secretion of nucleoside diphosphate kinase by mucoid Pseudomonas aeruginosa 8821: involvement of a carboxy-terminal motif in secretion.
    J Bacteriol. 2000 Jul;182(13):3826-31 PMID: 10851000
  6. Clinical and environmental isolates of Burkholderia cepacia exhibit differential cytotoxicity towards macrophages and mast cells.
    Mol Microbiol. 2000 Jun;36(6):1481-93 PMID: 10931297
  7. Immunologic properties of mast cells from rats infected with Nippostrongylus brasiliensis.
    J Immunol. 1975 Oct;115(4):1078-83 PMID: 51873
  8. The distribution of adenosine A1 receptors and 5'-nucleotidase in the hippocampal formation of several mammalian species.
    J Comp Neurol. 1986 Apr 22;246(4):427-34 PMID: 3009562
  9. Rat brain synaptosomal ATP:AMP-phosphotransferase activity.
    J Neurochem. 1989 Oct;53(4):1166-72 PMID: 2549198
  10. Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor.
    J Biol Chem. 1993 Apr 15;268(11):8199-203 PMID: 8463330
  11. Specificity of the protein secretory apparatus: secretion of the heat-labile enterotoxin B subunit pentamers by different species of gram- bacteria.
    Gene. 1995 Jan 11;152(1):41-5 PMID: 7828926
  12. Cholera.
    Clin Microbiol Rev. 1995 Jan;8(1):48-86 PMID: 7704895
  13. P2-purinergic receptors: subtype-associated signaling responses and structure.
    Annu Rev Pharmacol Toxicol. 1995;35:541-79 PMID: 7598506
  14. Regulation of ion channels by ABC transporters that secrete ATP.
    Science. 1995 Aug 11;269(5225):805-6 PMID: 7543697
  15. Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1.
    J Infect Dis. 1995 Oct;172(4):1126-9 PMID: 7561195
  16. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death.
    Immunol Today. 1995 Nov;16(11):524-8 PMID: 7495489
  17. Lysogenic conversion by a filamentous phage encoding cholera toxin.
    Science. 1996 Jun 28;272(5270):1910-4 PMID: 8658163
  18. A putative integrase gene defines the distal end of a large cluster of ToxR-regulated colonization genes in Vibrio cholerae.
    Microbiology. 1996 Aug;142 ( Pt 8):2165-74 PMID: 8760931
  19. ATP transport and ABC proteins.
    Chem Biol. 1996 Sep;3(9):703-6 PMID: 8939684
  20. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin.
    J Exp Med. 1997 Feb 3;185(3):579-82 PMID: 9053458
  21. Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111.
    Am J Trop Med Hyg. 1997 May;56(5):533-7 PMID: 9180604
  22. General secretion pathway (eps) genes required for toxin secretion and outer membrane biogenesis in Vibrio cholerae.
    J Bacteriol. 1997 Nov;179(22):6994-7003 PMID: 9371445
  23. A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains.
    Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3134-9 PMID: 9501228
  24. Induction of the lysogenic phage encoding cholera toxin in naturally occurring strains of toxigenic Vibrio cholerae O1 and O139.
    Infect Immun. 1998 Aug;66(8):3752-7 PMID: 9673258
  25. Nucleotide metabolizing ectoenzymes are upregulated in A431 cells periodically treated with cytostatic ATP leading to partial resistance without preventing apoptosis.
    Biochim Biophys Acta. 1998 Sep 16;1404(3):282-98 PMID: 9739153
  26. Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae.
    Microbiol Mol Biol Rev. 1998 Dec;62(4):1301-14 PMID: 9841673
  27. Secretion of ATP-utilizing enzymes, nucleoside diphosphate kinase and ATPase, by Mycobacterium bovis BCG: sequestration of ATP from macrophage P2Z receptors?
    Mol Microbiol. 1999 Mar;31(5):1333-43 PMID: 10200955
  28. Cutting edge: purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism.
    J Immunol. 1999 Jul 15;163(2):558-61 PMID: 10395640
  29. Identification of an ecto-nucleoside diphosphokinase and its contribution to interconversion of P2 receptor agonists.
    J Biol Chem. 1997 Aug 15;272(33):20402-7 PMID: 9252347
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2000-09-00
Pages
4930-7
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC101703
Subset
IM
Grants
NIAID NIH HHS · AI 16790-20 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]